Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Cushing's syndrome treatment Ketoconazole HRA receives European marketing authorization

Dec. 17, 2014

Bristol-Myers Squibb researchers prepare MGAT2 inhibitors

Dec. 17, 2014

FDA grants orphan drug status to ataluren for mucopolysaccharidosis type I

Dec. 17, 2014

OPKO Health and Pfizer enter into global agreement for hGH-CTP

Dec. 17, 2014

FDA approves Signifor LAR for acromegaly

Dec. 16, 2014

NEOD-001 given FDA fast track designation for AL amyloidosis

Dec. 16, 2014

Teijin Pharma reports new XO inhibitors

Dec. 16, 2014

Synageva BioPharma confirms active IND application for SBC-103

Dec. 16, 2014

ChemoCentryx reports topline data from phase II trial of CCX-140

Dec. 15, 2014

FDA accepts IND application for AGT-182 for the treatment of Hunter syndrome

Dec. 12, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...